These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35219532)

  • 1. Effect of IQOS introduction on Philip Morris International cigarette sales in Spain: a Logarithmic Mean Divisa Index decomposition approach.
    Golpe AA; Martín-Álvarez JM; Galiano A; Asensio E
    Gac Sanit; 2022; 36(4):293-300. PubMed ID: 35219532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of IQOS introduction on cigarette sales: evidence of decline and replacement.
    Stoklosa M; Cahn Z; Liber A; Nargis N; Drope J
    Tob Control; 2020 Jul; 29(4):381-387. PubMed ID: 31209129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults.
    Kim J; Yu H; Lee S; Paek YJ
    Tob Control; 2018 Nov; 27(Suppl 1):s74-s77. PubMed ID: 30158210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tobacco heated products: a new challenge in tobacco control].
    Peruga A; Rodríguez Lozano F; López MJ; Córdoba García R; Nerín I; Sureda X; Fernández E
    Gac Sanit; 2022; 36(1):57-59. PubMed ID: 33563478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free-Base and Total Nicotine, Reactive Oxygen Species, and Carbonyl Emissions From IQOS, a Heated Tobacco Product.
    Salman R; Talih S; El-Hage R; Haddad C; Karaoghlanian N; El-Hellani A; Saliba NA; Shihadeh A
    Nicotine Tob Res; 2019 Aug; 21(9):1285-1288. PubMed ID: 30476301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model.
    Lempert LK; Bialous S; Glantz S
    Tob Control; 2022 Aug; 31(e1):e83-e87. PubMed ID: 33811155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IQOS: examination of Philip Morris International's claim of reduced exposure.
    St Helen G; Jacob Iii P; Nardone N; Benowitz NL
    Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heated tobacco product regulation under US law and the FCTC.
    Lempert LK; Glantz SA
    Tob Control; 2018 Nov; 27(Suppl 1):s118-s125. PubMed ID: 30291201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQOS point-of-sale marketing strategies in Israel: a pilot study.
    Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
    Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic device or regulated tobacco product? Learning from the diffusion of heated tobacco products in Spain.
    Martín-Álvarez JM; Almeida A; Golpe AA; Asensio E
    Public Health; 2023 Jun; 219():61-66. PubMed ID: 37119795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.
    Bar-Zeev Y; Berg CJ; Khayat A; Romm KF; Wysota CN; Abroms LC; Elbaz D; Levine H
    Tob Control; 2023 Aug; 32(e2):e198-e204. PubMed ID: 35140170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heated tobacco products likely appeal to adolescents and young adults.
    McKelvey K; Popova L; Kim M; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s41-s47. PubMed ID: 30352843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.
    Glantz SA
    Tob Control; 2018 Nov; 27(Suppl 1):s9-s12. PubMed ID: 30131374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Household Surveys in the General Population and Web-Based Surveys in IQOS Users Registered at the Philip Morris International IQOS User Database: Protocols on the Use of Tobacco- and Nicotine-Containing Products in Germany, Italy, and the United Kingdom (Greater London), 2018-2020.
    Sponsiello-Wang Z; Langer P; Prieto L; Dobrynina M; Skiada D; Camille N; Weitkunat R; Lüdicke F
    JMIR Res Protoc; 2019 May; 8(5):e12061. PubMed ID: 31094340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'It's not what you'd term normal smoking': a qualitative exploration of language used to describe heated tobacco product use and associated user identity.
    East KA; Miller CR; Hitchman SC; McNeill A; Tompkins CNE
    Addiction; 2023 Mar; 118(3):533-538. PubMed ID: 36148622
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Berthet A; Butty A; Rossier J; Sadowski IJ; Froidevaux P
    Sci Rep; 2022 Jun; 12(1):10314. PubMed ID: 35725999
    [No Abstract]   [Full Text] [Related]  

  • 18. What Is Accounting for the Rapid Decline in Cigarette Sales in Japan?
    Cummings KM; Nahhas GJ; Sweanor DT
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32443663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke.
    Nabavizadeh P; Liu J; Havel CM; Ibrahim S; Derakhshandeh R; Jacob Iii P; Springer ML
    Tob Control; 2018 Nov; 27(Suppl 1):s13-s19. PubMed ID: 30206183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International.
    Levy DT; Warner KE; Liber AC; Travis N; Sweanor DT; Meza R; Cummings KM
    Nicotine Tob Res; 2023 Nov; 25(12):1899-1903. PubMed ID: 37535864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.